Avinger (NSDQ:AVGR) said today it launched its Pantheris lumivascular atherectomy system with extended nosecone in the European Union, touting that the device has been used in its first human patients. The device was used by Dr. Arne Schwindt in treating peripheral artery disease in three patients at Münster, Germany’s St. Franziskus Hospital, the Redwood City, Calif.-based company […]
Avinger
Avinger settles class-action investors suit for $5m
Avinger (NSDQ:AVGR) said today it inked a $5 million deal to settle a class-action investors suit against the company and several of its officers and directors. The deal comes after the company took part in a mediation related to the suit on February 8, which it said began discussions that ultimately led to the settlement. The Redwood […]
Avinger shares dive on Q4 sales slide
Shares in Avinger (NSDQ:AVGR) have tumbled today after the medical device maker missed expectation on Wall Street with its fourth quarter and full year 2017 earnings. The Redwood City, Calif.-based company posted losses of $8.6 million, or $12.58 per share, on sales of $1.9 million for the 3 months ended December 31, seeing losses shrink 28.2% […]
Avinger closes $18m Series B round
Avinger (NSDQ:AVGR) said late last week it closed a Series B round of convertible preferred stock, raising a total of $18 million prior to discounts and expenses. In conjunction with the round closing, the Redwood City, Calif.-based company said that lenders under its term loan agreement converted $38 million of debt into the company’s Series A convertible […]
Avinger prices $18m Series B
Avinger (NSDQ:AVGR) today priced an offering of Series B convertible preferred stock looking to raise a total of $18 million. In conjunction with the offering’s closing, the Redwood City, Calif.-based company said that lenders under its term loan agreement have agreed to convert $38 million of debt into the company’s Series A convertible preferred stock. Series B […]
Avinger pulls trigger on 1-for-40 reverse stock split
Avinger (NSDQ:AVGR) said this week it enacted a 1-for-40 reverse stock split of its common stock, effective yesterday, as it looks to satisfy the $1 minimum bid price requirement to be listed on Nasdaq. In the split, each shareholder in the Redwood City, Calif.-based company received a single share of common stock for every 40 shares they […]
Avinger bids for FDA nod for new Pantheris atherectomy device
A day after announcing CE Mark approval for the next generation of its Pantheris atherectomy device, Avinger (NSDQ:AVGR) said it’s seeking a similar nod from the FDA. The bid for 510(k) clearance from the federal safety watchdog for the image-guided device covers new features including a simpler, single-balloon system designed both for apposition and blood flow occlusion and […]
Avinger wins CE Mark for next-gen Pantheris atherectomy device
Avinger (NSDQ:AVGR) said today that it won CE Mark approval in the European Union for the next generation of its Pantheris image-guided atherectomy device. Redwood City, Calif.-based Avinger said the new device features a simpler, single-balloon system designed both for apposition and blood flow occlusion and improved pushability and tissue storage capacity. It’s designed to treat blocked […]
Avinger slashes jobs, Q3 sales down 61%
Avinger (Nasdaq:AVGR) – maker of the Lumivascular image-guided, catheter-based system to treat peripheral artery disease (PAD) – continued to experience declining sales as it retrenched during the third quarter, according to its newest earnings report. The Redwood, Calif.–based company has been cutting jobs and other costs– and focusing on existing accounts and winning FDA clearance for […]
Avinger inks $15m share purchase deal
Avinger (NSDQ:AVGR) said today it inked a $15 million stock purchase agreement with Lincoln Park Capital Fund. Through the deal, the Redwood City, Calif.-based company said it will have the right and sole discretion to sell $15 million worth of shares over a 30-month period to Lincoln Park Capital, with proceeds slated to support working capital […]
Avinger wins CE Mark for in-stent restenosis indication for image-guided atherectomy
Avinger (NSDQ:AVGR) said today that it won CE Mark approval for treating in-stent restenosis with its Pantheris Lumivascular atherectomy system. The company’s Lumivascular tech enables physicians to see from inside the artery during a directional atherectomy procedure in real-time, Avinger touted, using optical coherence tomography. The device is designed to help physicians more accurately navigate their […]